MMWR Vol. 65 / Early Release ► Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2–5 Years — United States, 2008–2014 | MMWR

MMWR Early Release Vol. 65, Early Release May 03, 2016

PDF

Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2–5 Years — United States, 2008–2014 
Susanna N. Visser, DrPH; Melissa L. Danielson, MSPH; Mark L. Wolraich, MD; et al.
MMWR Morb Mortal Wkly Rep 2016;65:(Early Release) 

The American Academy of Pediatrics 2011 guidelines recommend “behavior therapy” 

over medication as first-line treatment for children aged 4–5 years with attention 

deficit/hyperactivity disorder (ADHD). CDC analyzed Medicaid and employer-sponsored 

insurance (ESI) claims to assess national and state-level ADHD treatment patterns 

among young children. Among insured children aged 2–5 years receiving clinical 

care for ADHD, medication treatment was more common than receipt of recommended

first-line treatment with psychological services. Among children with ADHD who had ESI, 

receipt of psychological services did not increase after release of the 2011 guidelines.

Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2–5 Years — United States, 2008–2014 | MMWR